Zydus announces prices for its Covid drug Virafin approved by DCGI for use in moderate cases

Zydus Cadila on Tuesday announced the market price of Virafin, its drug that has been granted emergency use approval by the DCGI for the treatment of moderate cases of Covid-19.

Drug Firm Zydus Cadila has set the price of its medicine ‘Virafin' at Rs 11,995 per dose. After the DCGI's approval for use of this medicine in the treatment of moderate cases of Covid-19, the pharma giant has begun dispatching doses to its vendors. 'Virafin,' a single-use medication obtained emergency use clearance from the Drug Controller General of India (DCGI), the country's apex medicine regulator on April 23.